Tests:Procalcitonin: Difference between revisions
Tests:Procalcitonin
No edit summary |
Updated method Alinity |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 19: | Line 19: | ||
PCTN | PCTN | ||
|- | |- | ||
| | |Availability | ||
|Monday - Sunday, testing routinely available out of hours | |Monday - Sunday, testing routinely available out of hours | ||
|- | |- | ||
| Line 33: | Line 33: | ||
== Specimen Requirements == | == Specimen Requirements == | ||
|- | |- | ||
|Specimen | |Specimen | ||
|Plasma | |Plasma | ||
| Line 56: | Line 56: | ||
== Aliquot Requirements == | == Aliquot Requirements == | ||
|- | |- | ||
|Sample | |Sample | ||
|Serum | |Serum | ||
| Line 114: | Line 114: | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott Alinity | |Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| Line 133: | Line 133: | ||
* Treatments which stimulate the release of pro-inflammatory cytokines | * Treatments which stimulate the release of pro-inflammatory cytokines | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||
<!-- review-ping: 2026-09-14T08:14:30.627Z --> | |||